Blog
RSS FeedPosted by Michael Wonder on 06 Oct 2017
EMA takes yet another step in public engagement with its first public hearing
6 October 2017 - Summary report now published. ...
Posted by Michael Wonder on 26 Sep 2017
Drugs watchdog NICE attacks pharmaceutical industry in pricing dispute
25 September 2017 - Industry expert’s evidence is not independent, NICE argues. ...
Posted by Michael Wonder on 06 Sep 2017
Medical devices sponsor information day - 2017
6 September 2017 - TheTGA invites medical device sponsors and their staff to attend the Medical Devices Sponsor Information Day in ...
Posted by Michael Wonder on 01 Sep 2017
Provisional approval pathway for prescription medicines
1 September 2017 - The TGA would like to thank respondents who provided submissions in response to the March 2017 ...
Posted by Michael Wonder on 23 Aug 2017
Health Minister hears consumer case for health reform
23 August 2017 - Healthcare consumers have today put the case to Health Minister, Greg Hunt, for his National Health ...
Posted by Michael Wonder on 01 Aug 2017
Nomenclature of biological medicines
28 July 2017 - The TGA is seeking comments from interested parties on proposed options on whether there is a need ...
Posted by Michael Wonder on 29 Jul 2017
Concept paper on development and lifecycle of personalised medicines and companion diagnostic
28 July 2017 - Public consultation to end on 31 October 2017. ...
Posted by Michael Wonder on 25 Jul 2017
ICER seeks public comment on proposed value assessment framework for treatments that represent a potential major advance for serious ultra-rare conditions
25 July 2017 - ICER’s fundamental approach to value assessment remains constant with proposed changes for special circumstances. ...
Posted by Michael Wonder on 25 Jul 2017
PBAC to conduct stakeholder forum on the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
25 July 2017 - A stakeholder forum will be held for the post-market review of the use of biologics in the ...
Posted by Michael Wonder on 13 Jul 2017
Proposed revision to the procedure for the CADTH Common Drug Review and the CADTH Therapeutic Review Framework
13 July 2017 - CADTH is inviting stakeholder comments and feedback on proposed revisions to the Procedure for the CADTH Common ...
Posted by Michael Wonder on 19 May 2017
Post-market review of ezetimibe – notice of public consultation
19 May 2017 - The public consultation on the revised draft ezetimibe post-market review report to the PBAC will open ...
Posted by Michael Wonder on 18 May 2017
Clinical trial participants should have a say in new drug pricing
18 May 2017 - People who volunteer to participate in clinical trials of new drugs provide a valuable service to ...
Posted by Michael Wonder on 17 Apr 2017
Patients resort to paying consultants to help navigate Canada’s Byzantine health care system
14 April 2017 - Andrée Colella had been in and out of hospital for months with bladder and bone infections ...
Posted by Michael Wonder on 22 Mar 2017
Consumer involvement in their own healthcare – key to a sustainable national health system
21 March 2017 - The Secretary of the Federal Department of Health, Martin Bowles has recognised the importance of consumer involvement ...
Posted by Michael Wonder on 10 Feb 2017
Post-market review of pulmonary arterial hypertension medicines – public consultation
10 February 2017 - The public submission process is now open for the post-market review of pulmonary arterial hypertension medicines. ...